Where is Concert headquartered?

Concert is located in Lexington, MA.

Who invested in Concert?

Concert has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Concert?

Concert closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

concertpharma.com

Concert

Concert is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases.

Business Model:

Revenue: $42k

Employees: 51-200

Geographic Data

Address: 65 Hayden Avenue

City: Lexington

State: MA

Zip: 02421

Country: US

Financial Info

Stage:

post ipo equity

Raised Last:

$66M

Raised Total:

$271M

Social

Twitter

Crunchbase

Metrics

1,813,047Website Global Rank

12,377Website Monthly Traffic

Twitter Followers

Description

Concert is a Massachusetts-based biopharmaceutical company that researches and develops small-molecule drugs for the treatment of autoimmune diseases.

Contact Phone:
+17818600045

Contact Email:

IPO Details

Concert went public on 2/13/2014 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
2/13/2014

Ticker Symbol:
CNCE

Amount Raised:
$84M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
6/2022	Post-IPO Equity	2	$66.4M	BVF Partners RA Capital Management BVF Partners RA Capital Management
6/2011	Venture Round	1	$4M	GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline
11/2006	Series B	8	$48.5M	Flagship Pioneering TVM Capital Three Arch Partners Skyline Ventures QVT Financial New Leaf Venture Partners Greylock Brookside Capital Flagship Pioneering
11/2021	Post-IPO Equity		$65M	BVF Partners L.P RA Capital Management
2/2014	IPO		$84M
7/2006	Series A	5	$10M	TVM Capital Three Arch Partners Skyline Ventures QVT Financial Greylock
4/2008	Series C		$0	QVT Financial Skyline Ventures Mediphase Venture Partners TVM Capital Three Arch Partners New Leaf Venture Partners Adage Capital Management Brookside Capital Flagship Pioneering Greylock GSK Westfield Capital Management QVT Financial Skyline Ventures Mediphase Venture Partners TVM Capital Three Arch Partners New Leaf Venture Partners Adage Capital Management Brookside Capital Flagship Pioneering Greylock GSK Westfield Capital Management
11/2010	Grant		$488k
6/2017	Post-IPO Debt	1	$30M	Hercules Capital Hercules Capital Hercules Capital Hercules Capital
1/2020	Post-IPO Equity		$74.7M
4/2008	Series C	12	$37M	QVT Financial Skyline Ventures Mediphase Venture Partners TVM Capital Three Arch Partners New Leaf Venture Partners QVT Financial Skyline Ventures Mediphase Venture Partners TVM Capital Three Arch Partners New Leaf Venture Partners

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details